Aktana Stock
Life sciences data-fueled insights
Sign up today and learn more about Aktana Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Aktana Stock
Aktana helps life science companies get the most out of artificial intelligence (AI) for commercializing their products. The company’s proprietary platform harnesses machine learning algorithms to enable marketing and sales teams to optimize their engagement with prescribing physicians. Aktana supports more than 100 brands and more than half the top 20 pharmaceutical companies worldwide to increase revenue, capitalize on data investments, and drive channel productivity and results. The company’s focus on the life sciences market allows Aktana to understand and incorporate unique market dynamics more deeply than the major AI players. Headquartered in San Francisco, Aktana also has offices in New York, Philadelphia, London, Barcelona, Tokyo, Osaka, and Shanghai.
Investors
Funding History
August 2011 | $3.0M |
---|---|
May 2012 | $2.0M |
June 2013 | $5.5M |
June 2016 | $17.6M |
September 2018 | $21.0M |
September 2019 | $20.0M |
Management
Chief Executive Officer
David Ehrlich
Chief Customer Officer
James Anderson
Chief Science Officer
Pini Ben-Or
Chief Financial Officer
Colm Callan
Chief Marketing Officer
Clay Hausmann
Chief Technology Officer
Jin Huang
Press
businesswire - Mar, 5 2024
Aktana Announces Release of Next Generation Omnichannel Orchestration Tools Designed for Medical Technology Companiesbusinesswire - Nov, 1 2023
Aktana Acquires Tact.ai’s Field Engagement and Conversational AI Technologybusinesswire - Jun, 27 2023
Aktana Announces New CEOzpr - Jun, 7 2023
Aktana Announces Contextual Intelligence 360 for Product Launchpharmiweb - Nov, 11 2022
Aktana Named Trailblazer in Commercial Analytics & AI Assessment by Everest Group